Astria Therapeutics, Inc.

Biotechnology • Healthcare • Boston, MA, United States • ATXS (NGM)

Astria Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. Its lead product candidate is navenibart, a monoclonal antibody inhibitor of plasma kallikrein, which is in Phase 1b/2 clinical trials for the treatment of hereditary angioedema. The company is also developing STAR-0310, a monoclonal antibody OX40 antagonist that is in clinical development for the treatment of atopic dermatitis, an immune disorder associated with loss of skin barrier function and itching. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is headquartered in Boston, Massachusetts.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Astria Therapeutics Stock Rallies 37% on $700M Buyout Offer From BCRX - Yahoo Finance

Yahoo Finance • Oct 15

BioCryst Pharmaceuticals To Acquire Astria Therapeutics In $700 Million Cash-and-Stock Deal - Nasdaq

Nasdaq • Oct 14

BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile - Business Wire

Business Wire • Oct 14

BioCryst to Acquire Astria Therapeutics in $700 Million Deal - Contract Pharma

Contract Pharma • Oct 14

BioCryst goes ‘all in’ on rare swelling disease with Astria deal - BioPharma Dive

BioPharma Dive • Oct 14

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Astria Therapeutics, Inc. had layoffs?

No layoff events have been recorded for Astria Therapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Astria Therapeutics, Inc. have?

Astria Therapeutics, Inc. has approximately 78 employees.

What industry is Astria Therapeutics, Inc. in?

Astria Therapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Astria Therapeutics, Inc. a publicly traded company?

Yes, Astria Therapeutics, Inc. is publicly traded under the ticker symbol ATXS on the NGM. The company has a market capitalization of approximately $0.74 billion.

Where is Astria Therapeutics, Inc. headquartered?

Astria Therapeutics, Inc. is headquartered in Boston, MA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.